#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myositis Immunodeficiency Wiskott-Aldrich syndrome Liver abscess Acquired haemophilia Immune-mediated myasthenia gravis Metastatic malignant melanoma Becker's muscular dystrophy Bronchopulmonary dysplasia Glomerulonephritis Fabry's disease Leiomyosarcoma recurrent Extranodal marginal zone B-cell lymphoma (MALT type) Chronic hepatitis B Rosai-Dorfman syndrome More trials…

    Learn about Rare Diseases

    Hyperoxaluria Pituitary-dependent Cushing’s syndrome – Diagnostics VEXAS syndrome – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Waldenstrom’s macroglobulinaemia – Diagnostics Myxofibrosarcoma Alagille syndrome – Trials in Disease Pelizaeus-Merzbacher disease – Treatment Systemic mastocytosis – Life with Disease Lymphangiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Varenicline Iptacopan Hydrochloride Histamine Dihydrochloride Dipyridamole Andexanet Alfa Fludarabine Crizanlizumab Zinc Acexamate Everolimus Bisacodyl Midazolam METAMIZOLE SODIUM Dermatophagoides Farinae Povetacicept Daratumumab Entrectinib Jnj-81241459 Recombinant Interferon Beta-1B Ambrosia Artemisiifolia (302) Sar442970 More therapies…

    Learn about Your Condition

    Colitis ulcerative Large cell lung cancer Acquired ATTR amyloidosis Skin angiosarcoma Ankylosing spondylitis Postoperative wound infection Primary hyperthyroidism Chordoma Ocular hypertension Pancreatic carcinoma recurrent Myelodysplastic syndrome Cystic fibrosis Primary biliary cholangitis Fibromyalgia Erosive oesophagitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    Investigated Drugs:
    • Bomedemstat
    • Hydroxycarbamide
    Austria Denmark France Germany Hungary Italy +3

  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Methylprednisolone Sodium Succinate
    • Levetiracetam
    Italy

  • Study of Relatlimab, Nivolumab, and 5-Azacytidine for Acute Myeloid Leukemia in Patients Not Eligible for Intensive Chemotherapy

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Relatlimab
    • Azacitidine
    • Nivolumab
    Germany

  • Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Mosunetuzumab
    • Tocilizumab
    Italy

  • Study of Ponatinib for Patients with Resistant Chronic Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Ponatinib
    France Poland

  • Study on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Obinutuzumab
    • Rituximab
    Poland
Previous Page
1 … 59 60 61 62 63 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!